MannKind enters into 7th amendment to supply pact with Amphastar

On December 22 MannKind (MNKD) entered into a Seventh Amendment to Supply Agreement with Amphastar Pharmaceuticals (AMPH) pursuant to which the parties amended the Supply Agreement, dated July 31 as amended Pursuant to the Seventh Amendment, the parties agreed to, among other things, accommodate a change in the source of inclusion bodies by restructuring the annual purchase commitments and implementing a capacity fee for certain future periods Prior to the Seventh Amendment, the Company was committed to purchase commitments totaling EUR 58.7 M in the aggregate over calendar years 2024-27. The parties also agreed to extend the term of the Supply Agreement until the later of December 31, 2035 or until the completion of all purchase commitments.